Cite
HARVARD Citation
Takahashi, D. et al. (2021). Adjuvant S‐1 vs gemcitabine for node‐positive perihilar cholangiocarcinoma: A propensity score‐adjusted analysis. Journal of hepato-biliary-pancreatic sciences. pp. 716-726. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Takahashi, D. et al. (2021). Adjuvant S‐1 vs gemcitabine for node‐positive perihilar cholangiocarcinoma: A propensity score‐adjusted analysis. Journal of hepato-biliary-pancreatic sciences. pp. 716-726. [Online].